BraveRX Review

BraveRX is a current U.S. telehealth platform focused on adult erectile-dysfunction treatment. Current terms identify Brave Labs LLC as the operator and state that BraveRX is not itself the medical provider or pharmacy. Prescribing and dispensing are performed by separate healthcare entities.

The terms identify Beluga Health as an example medical group and Madame Rx LLC, doing business as Chemistry Rx, as an example pharmacy. Chemistry Rx's official site lists the same Folcroft, Pennsylvania address and describes its specialty compounding work. These disclosures do not guarantee which clinician or pharmacy will handle an individual order.

BraveRX names Jonah Mink, MD, NPI 1083052351, as a Beluga Health provider for required telemedicine disclosures. NPPES returns one active exact-number record for Jonah Mink, MD, with Family Medicine as the primary taxonomy and a Pennsylvania license. That record verifies the disclosed identity, not the clinician assigned to every patient.

The standard intake starts with an online questionnaire and medication preference. A licensed clinician reviews the submitted health information, may request more information, and may prescribe only when clinically appropriate. A government-issued photo ID is required before the initial order ships.

BraveRX says the consultation is complimentary with an approved and completed order. The card is temporarily authorized during review, and the hold is released without a charge if the medical team declines the prescription. Most approvals are described as occurring within 24 hours, but missing information can delay the decision.

Surge Max is a compounded as-needed sublingual tablet containing sildenafil 40 mg, tadalafil 15 mg, and apomorphine 3 mg. Current standard prices are $119 for six tablets, $179 for twelve, and $229 for eighteen. The site advertises placement under the tongue before sexual activity, but the prescription label and clinician instructions should control use.

Surge Daily Pro is a compounded daily sublingual tablet containing tadalafil 6 mg, apomorphine HCl 3 mg, and icariin 100 mg. The current 30-tablet price is $179. It is the only current product presented as a daily regimen.

Prime Max Pro is a compounded as-needed capsule containing tadalafil 10 mg, vardenafil 10 mg, apomorphine 2 mg, and L-citrulline 250 mg. Current standard prices are $139 for seven capsules and $199 for fourteen. The product title says Prime Max Pro, while the detail copy calls it As-Needed Pro.

Prime Max Core is a compounded as-needed capsule containing tadalafil 10 mg and vardenafil 10 mg. Current standard prices are $99 for seven capsules and $159 for fourteen. The product title and detail-copy name also differ, using Prime Max Core and As-Needed Core.

The current site advertises OFFER20 for $20 off a first order and displays discounted examples on the treatment selector. The standard prices remain the stable comparison point. The coupon is temporary, and compatibility with the issued affiliate tracking link has not been established.

No monthly average is shown. The quantities represent different numbers of tablets or capsules, use varies for as-needed products, and each formula combines different active ingredients and service assumptions. Averaging those prices would not produce a like-for-like monthly treatment cost.

FDA states that compounded drugs are not FDA approved and are not reviewed before marketing for safety, effectiveness, or quality. Sildenafil, tadalafil, vardenafil, and apomorphine each have approved uses, but that status does not transfer to BraveRX's compounded combinations or to every ingredient's use in an ED formula.

BraveRX's safety page warns that PDE5 inhibitors should not be used with nitrate medications or riociguat. It also warns that apomorphine should not be used with 5-HT3 antagonist antiemetics such as ondansetron because of severe hypotension and loss-of-consciousness risk. The clinician needs a complete medication and health history before selecting a formula.

BraveRX says it is available in every U.S. state except North Dakota. The platform's broader partners may operate nationally, but the selected treatment still depends on clinician licensure, medical eligibility, pharmacy service, and the patient's physical location at the time of care.

The intake advertises plain, unmarked packaging, tracking within two business days, and included package protection. The contact FAQ says processed orders typically ship within 48 hours. These are provider estimates rather than guaranteed end-to-end delivery times, and clinical review can extend the timeline.

Product pages and intake screens advertise free discreet shipping. The operative terms instead permit shipping and handling charges and state that subscription products are charged shipping. Checkout should control the actual fee, and the order summary should be saved.

Current terms say monthly subscriptions dispatch every 28 days. Refill cancellation or modification should be submitted by phone, email, or patient portal at least 72 hours before scheduled processing. Pauses and address changes should be completed at least three days before the next billing date.

Prescription products cannot be returned after shipment. A damaged product should be reported within seven days, and BraveRX may request photographs or a return at the customer's cost. Replacement, credit, and full or partial refunds are discretionary and limited to the amount paid for that month's product.

Customer support is available by phone, customercare@braverx.com, chat, and the patient portal. The current contact page lists Monday through Sunday, 9 a.m. to 7 p.m. Eastern, while several official footers list Monday through Friday, 9 a.m. to 6 p.m. Eastern. Separate 24/7 language concerns access to licensed medical professionals, not a guaranteed customer-care response time.

The privacy policy says BraveRX is not a HIPAA covered entity and may be a business associate in some contexts. Later text labels all identifying information as PHI protected under HIPAA. Because those statements conflict, this review does not make a blanket HIPAA-compliance claim for every BraveRX interaction.